|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes |
| Prodrug | nepafenac |
IUPAC Name ![]() |
| 2-[2-amino-3-(benzoyl)phenyl]acetic acid |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 4363 | amfenac |
Synonyms ![]() |
| AHR-5850D |
| Fenazox® (Japan) |
Database Links ![]() |
|
| CAS Registry No. | 51579-82-9 |
| ChEBI | CHEBI:75915 |
| ChEMBL Ligand | CHEMBL25146 |
| PubChem CID | 2136 |
| Search Google for chemical match using the InChIKey | SOYCMDCMZDHQFP-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | SOYCMDCMZDHQFP |
| Search PubMed clinical trials | amfenac |
| Search PubMed titles | amfenac |
| Search PubMed titles/abstracts | amfenac |
| Wikipedia | Amfenac |
| Comments |
| Amfenac is the active metabolite of nepafenac. It is a potent non-steroidal antiinflammatory drug (NSAID) [2]. Marketed formulations may contain amfenac sodium (PubChem CID 23665728). |